(Q50104068)

25 February 2018

title

Up-to-date knowledge about the association between multiple sclerosis and the reactivation of human endogenous retrovirus infections (English)

1 reference

25 February 2018

author name string

Borros Arneth

series ordinal

1

1 reference

25 February 2018

publication date

8 February 2018

1 reference

25 February 2018

published in

Journal of Neurology

1 reference

25 February 2018

Inhibition of multiple-sclerosis-associated retrovirus as biomarker of interferon therapy

cites work

1 reference

12 December 2020

Novel reliable real-time PCR for differential detection of MSRVenv and syncytin-1 in RNA and DNA from patients with multiple sclerosis

1 reference

12 December 2020

Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis

1 reference

12 December 2020

Expression of HERV-Fc1, a human endogenous retrovirus, is increased in patients with active multiple sclerosis

1 reference

12 December 2020

No additional copies of HERV-Fc1 in the germ line of multiple sclerosis patients

1 reference

12 December 2020

Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis

1 reference

12 December 2020

Design and screening of a glial cell-specific, cell penetrating peptide for therapeutic applications in multiple sclerosis.

1 reference

12 December 2020

Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms

1 reference

12 December 2020

Cytokine control of inflammation and repair in the pathology of multiple sclerosis.

1 reference

12 December 2020

Human endogenous retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods

1 reference

12 December 2020

The DNA copy number of human endogenous retrovirus-W (MSRV-type) is increased in multiple sclerosis patients and is influenced by gender and disease severity

1 reference

12 December 2020

Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation

1 reference

12 December 2020

(Some) cellular mechanisms influencing the transcription of human endogenous retrovirus, HERV-Fc1.

1 reference

12 December 2020

Plasmacytoid dendritic cells in the duodenum of individuals diagnosed with myalgic encephalomyelitis are uniquely immunoreactive to antibodies to human endogenous retroviral proteins.

1 reference

12 December 2020

Multiple sclerosis: molecular mechanisms and therapeutic opportunities

1 reference

12 December 2020

Flow cytometric assay detecting cytotoxicity against human endogenous retrovirus antigens expressed on cultured multiple sclerosis cells

1 reference

12 December 2020

Multiple sclerosis: autoimmunity and viruses

1 reference

12 December 2020

Genomic analysis of ERVWE2 locus in patients with multiple sclerosis: absence of genetic association but potential role of human endogenous retrovirus type W elements in molecular mimicry with myelin antigen.

1 reference

12 December 2020

The benefits and detriments of macrophages/microglia in models of multiple sclerosis

1 reference

12 December 2020

Is a hypothetical melanoma-like neuromelanin the underlying factor essential for the aetiopathogenesis and clinical manifestations of multiple sclerosis?

1 reference

12 December 2020

Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort study

1 reference

12 December 2020

Role of toll-like receptors in multiple sclerosis

1 reference

12 December 2020

'There and back again': revisiting the pathophysiological roles of human endogenous retroviruses in the post-genomic era

1 reference

12 December 2020

Monoclonal antibodies in treatment of multiple sclerosis

1 reference

12 December 2020

Monoclonal antibodies as disease modifying therapy in multiple sclerosis.

1 reference

12 December 2020

Association of endogenous retroviruses and long terminal repeats with human disorders

1 reference

12 December 2020

Expression of human endogenous retrovirus-w including syncytin-1 in cutaneous T-cell lymphoma

1 reference

12 December 2020

Comprehensive analysis of human endogenous retrovirus group HERV-W locus transcription in multiple sclerosis brain lesions by high-throughput amplicon sequencing

1 reference

12 December 2020

Estrogen receptor (ER) β expression in oligodendrocytes is required for attenuation of clinical disease by an ERβ ligand

1 reference

12 December 2020

Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis?

1 reference

12 December 2020

Role of pathogens in multiple sclerosis

1 reference

12 December 2020

Erratum: Genomic analysis of ERVWE2 locus in patients with Multiple sclerosis: absence of genetic association but potential role of Human Endogenous retrovirus type W elements in molecular mimicry with myelin antigen

1 reference

12 December 2020

HERV-W polymorphism in chromosome X is associated with multiple sclerosis risk and with differential expression of MSRV.

1 reference

12 December 2020

CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis

1 reference

12 December 2020

The effect of cellular differentiation on HSV-1 infection of oligodendrocytic cells.

1 reference

12 December 2020

Human endogenous retrovirus HERV-Fc1 association with multiple sclerosis susceptibility: a meta-analysis

1 reference

12 December 2020

Secondary progressive and relapsing remitting multiple sclerosis leads to motor-related decreased anatomical connectivity

1 reference

12 December 2020

Human endogenous retroviruses and the nervous system

1 reference

12 December 2020

A complex role of herpes viruses in the disease process of multiple sclerosis

1 reference

12 December 2020

Biomarkers of therapeutic response in multiple sclerosis: current status

1 reference

12 December 2020

Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells.

1 reference

12 December 2020

Ultrasonographic evaluation of cerebral arterial and venous haemodynamics in multiple sclerosis: a case-control study

1 reference

12 December 2020

A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients

1 reference

12 December 2020

Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein

1 reference

12 December 2020

Genetic variants are major determinants of CSF antibody levels in multiple sclerosis

1 reference

12 December 2020

Transcriptional activity of human endogenous retroviruses in human peripheral blood mononuclear cells

1 reference

12 December 2020

The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.

1 reference

12 December 2020

Inflammatory response of endothelial cells to a human endogenous retrovirus associated with multiple sclerosis is mediated by TLR4.

1 reference

12 December 2020

Are human endogenous retroviruses triggers of autoimmune diseases? Unveiling associations of three diseases and viral loci

1 reference

12 December 2020

Genes and Environment in Multiple Sclerosis project: A platform to investigate multiple sclerosis risk

1 reference

12 December 2020

Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis

1 reference

12 December 2020

Multiple Sclerosis between Genetics and Infections: Human Endogenous Retroviruses in Monocytes and Macrophages

1 reference

12 December 2020

Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis

1 reference

12 December 2020

Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

1 reference

12 December 2020

The High Prevalence of the Varicella Zoster Virus in Patients With Relapsing-Remitting Multiple Sclerosis: A Case-Control Study in the North of Iran

1 reference

12 December 2020

Integration and Fixation Preferences of Human and Mouse Endogenous Retroviruses Uncovered with Functional Data Analysis

1 reference

12 December 2020

Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis

1 reference

12 December 2020

Contribution of type W human endogenous retroviruses to the human genome: characterization of HERV-W proviral insertions and processed pseudogenes

1 reference

12 December 2020

Comprehension of confidence intervals - development and piloting of patient information materials for people with multiple sclerosis: qualitative study and pilot randomised controlled trial

1 reference

12 December 2020

A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives

1 reference

12 December 2020

Outcome Measures in Clinical Trials for Multiple Sclerosis.

1 reference

12 December 2020

The association between human endogenous retroviruses and multiple sclerosis: A systematic review and meta-analysis

1 reference

12 December 2020

Multiple sclerosis: an example of pathogenic viral interaction?

1 reference

12 December 2020

Cooccurrences of Putative Endogenous Retrovirus-Associated Diseases

1 reference

12 December 2020

EnHERV: Enrichment analysis of specific human endogenous retrovirus patterns and their neighboring genes

1 reference

12 December 2020

Friends-Enemies: Endogenous Retroviruses Are Major Transcriptional Regulators of Human DNA

1 reference

12 December 2020

Type W Human Endogenous Retrovirus (HERV-W) Integrations and Their Mobilization by L1 Machinery: Contribution to the Human Transcriptome and Impact on the Host Physiopathology.

1 reference

12 December 2020

10.1007/S00415-018-8783-1

Identifiers

DOI

1 reference

25 February 2018

1 reference

25 February 2018